Dempze Nancy E increased its stake in AptarGroup, Inc. (NYSE:ATR – Free Report) by 0.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,253 shares of the industrial products company’s stock after acquiring an additional 217 shares during the period. AptarGroup makes up about 2.1% of Dempze Nancy E’s holdings, making the stock its 18th largest holding. Dempze Nancy E’s holdings in AptarGroup were worth $3,653,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Stonebridge Financial Group LLC purchased a new position in shares of AptarGroup in the 4th quarter valued at about $42,000. Park Place Capital Corp acquired a new stake in AptarGroup in the fourth quarter valued at approximately $67,000. Principal Securities Inc. lifted its stake in AptarGroup by 328.4% in the fourth quarter. Principal Securities Inc. now owns 437 shares of the industrial products company’s stock worth $69,000 after acquiring an additional 335 shares during the last quarter. Huntington National Bank grew its holdings in AptarGroup by 35.1% during the 4th quarter. Huntington National Bank now owns 462 shares of the industrial products company’s stock worth $73,000 after acquiring an additional 120 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of AptarGroup by 310.4% in the 4th quarter. Jones Financial Companies Lllp now owns 591 shares of the industrial products company’s stock valued at $93,000 after purchasing an additional 447 shares during the last quarter. 88.52% of the stock is currently owned by hedge funds and other institutional investors.
AptarGroup Trading Down 5.8 %
NYSE:ATR opened at $140.09 on Friday. The company has a market capitalization of $9.32 billion, a PE ratio of 25.29, a P/E/G ratio of 3.89 and a beta of 0.56. AptarGroup, Inc. has a 52-week low of $135.96 and a 52-week high of $178.03. The stock’s 50 day moving average price is $148.57 and its 200 day moving average price is $158.45. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.28.
AptarGroup Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 5th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date of this dividend was Wednesday, February 5th. AptarGroup’s dividend payout ratio is currently 32.49%.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the stock. Raymond James reaffirmed an “outperform” rating and set a $190.00 price objective (down from $200.00) on shares of AptarGroup in a research report on Monday, February 10th. Wells Fargo & Company lowered their price objective on AptarGroup from $180.00 to $170.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Robert W. Baird cut their target price on AptarGroup from $185.00 to $160.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Bank of America downgraded AptarGroup from a “buy” rating to a “neutral” rating and set a $173.00 price target for the company. in a report on Monday, January 6th. Finally, StockNews.com cut shares of AptarGroup from a “buy” rating to a “hold” rating in a report on Monday, February 10th. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $181.60.
Get Our Latest Stock Analysis on AptarGroup
AptarGroup Company Profile
AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.
Featured Stories
- Five stocks we like better than AptarGroup
- What Are Dividend Champions? How to Invest in the Champions
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How Technical Indicators Can Help You Find Oversold Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Dividend Capture Strategy: What You Need to Know
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.